Related Experiment Video
Updated: Mar 8, 2026
14:14
Adaptation of Semiautomated Circulating Tumor Cell CTC Assays for Clinical and Preclinical Research Applications
Published on: February 28, 2014
16.3K
Lessons Learned: Transfer of the High-Definition Circulating Tumor Cell Assay Platform to Development as a
P Kuhn1, S M Keating2, G T Baxter2
1The Scripps Research Institute, La Jolla, California, USA.
Clinical Pharmacology and Therapeutics
|February 5, 2017
Summary
Transferring academic technology platforms to start-ups for medical diagnostics is complex. This review details key steps and lessons learned for successful commercialization and regulatory approval.
Area of Science:
- Biotechnology
- Medical Diagnostics
- Technology Transfer
Background:
- Academic research often yields novel technology platforms with commercial potential.
- Transitioning these platforms to industry for product development presents significant challenges.
Purpose of the Study:
- To outline the critical steps and practical lessons learned during the transfer of an academic technology platform to a start-up.
- To provide a development toolkit for academic groups and start-ups pursuing commercialization and regulatory approval for medical diagnostic products.
Main Methods:
- Review of a specific case study involving technology transfer from academia to a start-up.
- Analysis of the processes, challenges, and outcomes of this transfer.
Main Results:
- Identification of key milestones in the technology transfer process.
- Documentation of critical success factors and potential pitfalls.
Conclusions:
- Successful technology transfer requires strategic planning, resource management, and a clear understanding of commercialization pathways.
- The outlined approach can guide academic institutions and start-ups in navigating the complexities of medical diagnostic product development.
